Peter Adamson joined Sanofi in late March, as the coronavirus pandemic surged around the world and changed lives and livelihoods. Someday, he says, he’ll take up his new role in Cambridge, Mass., as global development therapeutic area head for oncology in general and pediatric innovation in particular, but for now he is leading and learning from his home in South Jersey.
A pediatric oncologist, Adamson spent the last 30 years caring for children and doing cancer research. He was a professor of pediatrics and pharmacology at the Perelman School of Medicine at the University of Pennsylvania and at the Children’s Hospital of Pennsylvania (CHOP). For the past 10 years, he chaired the Children’s Oncology Group, an international consortium supported by the National Cancer Institute whose 230 members carry out translational research and large-scale clinical trials in children and adolescents with cancer.